MoonLake Immunotherapeutics (MLTX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 845K | 751K | 0 | 742K | 0 | 0 | 32.52K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.49K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -845K | -751K | 0 | -742K | 0 | 0 | -32.52K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.49K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | 100% | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - |
| Operating Expenses | 69.18M | 64.47M | 71.43M | 59.96M | 47.48M | 49.58M | 43.08M | 30.58M | 19.82M | 15.03M | 12.98M | 13.19M | 12.93M | 16.7M | 14.77M | 17.65M | 15.94M | 14.27M | 6.27M | 32.68M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 15.51M | 9.21M | 10.8M | 10.94M | 11.03M | 9.22M | 7.38M | 6.92M | 6.81M | 6.93M | 5.39M | 4.48M | 5.52M | 5.33M | 5.75M | 6.25M | 5.49M | 9.28M | 5.6M | 2.81M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 53.67M | 57.49M | 60.63M | 49.02M | 36.46M | 40.36M | 35.7M | 23.66M | 13.01M | 8.1M | 7.59M | 8.7M | 7.42M | 11.37M | 9.02M | 11.4M | 10.45M | 4.99M | 669.53K | 29.87M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -70.02M | -65.22M | -71.43M | -60.7M | -47.48M | -49.58M | -43.11M | -30.58M | -19.82M | -15.03M | -12.98M | -13.19M | -12.93M | -16.7M | -14.77M | -17.65M | -15.94M | -14.28M | -6.27M | -32.68M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -47.47% | -31.54% | -65.69% | -98.5% | -139.58% | -229.9% | -232.23% | -131.9% | -53.27% | 9.99% | 12.14% | 25.3% | 18.89% | -16.94% | -135.68% | 45.99% | -16840.81% | - | - | - |
| EBITDA | -69.18M | -64.47M | -70.69M | -59.96M | -47.11M | -48.28M | -43.08M | -30.24M | -19.49M | -15.03M | -12.97M | -13.18M | -12.93M | -16.69M | -14.77M | -17.65M | -15.94M | -14.27M | -6.26M | -32.68M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -46.86% | -33.53% | -64.09% | -98.29% | -141.67% | -221.31% | -232.06% | -129.36% | -50.77% | 9.99% | 12.15% | 25.31% | 18.89% | -16.94% | -135.71% | 46% | -20793.46% | - | - | - |
| D&A (Non-Cash Add-back) | 845K | 751K | 745K | 742K | 378K | 1.3M | 32.52K | 342K | 328K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 2.49K | 2.49K | 2.27K | 0 |
| EBIT | -70.02M | -60.77M | -67.38M | -53.92M | -40.39M | -49.58M | -36.02M | -24.68M | -13.9M | -15.03M | -12.98M | -13.19M | -12.93M | -16.7M | -14.77M | -17.65M | -15.94M | -14.31M | -6.27M | -32.68M |
| Net Interest Income | -2.27M | -2M | -3.2M | -2.04M | -18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.27M | 2M | 3.2M | 2.04M | 18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 939K | 2.45M | 855K | 4.74M | 7.08M | 3.23M | 7.09M | 5.9M | 5.92M | 7.19M | 1.39M | 842.65K | 723.59K | 239.5K | 37.59K | 245.13K | 69.51K | -36.01K | -20.84K | -3.78K |
| Pretax Income | -69.08M | -62.77M | -70.58M | -55.96M | -40.41M | -46.35M | -36.02M | -24.68M | -13.9M | -7.84M | -11.59M | -12.34M | -12.21M | -16.46M | -14.73M | -17.41M | -15.87M | -14.31M | -6.29M | -32.69M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 622K | 248K | 115K | 95K | 153K | 41.14K | 92.11K | 79K | 70K | 44.31K | 28.92K | 10.15K | 11.01K | 11.01K | 8.74K | 9.28K | 7.33K | 4.75K | 0 | 0 |
| Effective Tax Rate % | -0.9% | -0.4% | -0.16% | -0.17% | -0.38% | -0.09% | -0.26% | -0.32% | -0.5% | -0.56% | -0.25% | -0.08% | -0.09% | -0.07% | -0.06% | -0.05% | -0.05% | -0.03% | 0% | 0% |
| Net Income | -69.71M | -62.43M | -69.73M | -55.22M | -39.94M | -45.6M | -35.39M | -24.27M | -13.67M | -7.44M | -9.43M | -10.14M | -9M | -1.94M | -10.11M | -12.12M | -15.88M | -14.32M | -6.29M | -32.69M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -74.51% | -36.89% | -97.03% | -127.55% | -192.14% | -513.2% | -275.45% | -139.34% | -51.84% | -284.32% | 6.77% | 16.35% | 43.29% | 86.48% | -60.79% | 62.92% | -20715.22% | - | - | - |
| Net Income (Continuing) | -69.71M | -63.02M | -70.69M | -56.05M | -40.56M | -46.4M | -36.11M | -24.76M | -13.97M | -7.89M | -11.62M | -12.35M | -12.22M | -16.47M | -14.74M | -17.42M | -15.88M | -14.32M | -6.29M | -32.69M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 2.29M | 4.21M | 5.06M | 6.57M | 7.31M | 9.37M | 9.83M | 17.82M | 64.71M | 9.31M | 17.11M | 19.87M | 27.28M | 31.04M | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.98 | -0.93 | -1.10 | -0.87 | -0.63 | -0.72 | -0.56 | -0.39 | -0.22 | -0.12 | -0.18 | -0.23 | -0.31 | -0.05 | -0.40 | -0.49 | -0.43 | -0.06 | -0.17 | -0.89 |
| EPS Growth % | -55.56% | -29.17% | -96.43% | -123.08% | -186.36% | -500% | -211.11% | -69.57% | 29.03% | -140.96% | 55% | 53.06% | 27.91% | 17.28% | -135.29% | 44.94% | - | - | - | - |
| EPS (Basic) | -0.98 | -0.93 | -1.10 | -0.87 | -0.63 | -0.72 | -0.56 | -0.39 | -0.22 | -0.12 | -0.18 | -0.23 | -0.31 | -0.05 | -0.40 | -0.49 | -0.43 | -0.06 | -0.17 | -0.89 |
| Diluted Shares Outstanding | 71.27M | 64.46M | 63.37M | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | 59.91M | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 36.93M | 36.93M | 36.93M |
| Basic Shares Outstanding | 71.27M | 64.46M | 63.37M | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | 59.91M | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 36.93M | 36.93M | 36.93M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |